Drug and Therapeutics Bulletin 1994;32:62-63; doi:10.1136/dtb.1994.32862
Copyright © 1994 by the BMJ Publishing Group Ltd.
Cisplatin or carboplatin for ovarian and testicular cancer?
Relevant BNF section: 8.1.5
Carboplatin was introduced in 1986 as a less toxic alternative to cisplatin. When we reviewed the drugs seven years ago1 it was not clear whether carboplatin could replace cisplatin in the treatment of cancer, and the debate has continued. In this article we compare the two products for the treatment of ovarian and testicular cancer.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Endocrine system
-
Urinary and genital tract disorders
-
Malignant disease and immunosuppression
-
Endocrinology
-
Oncology
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
